128 related articles for article (PubMed ID: 18951284)
1. DNA cleavage, binding and intercalation studies of drug-based oxovanadium(IV) complexes.
Patel MN; Chhasatia MR; Patel SH; Bariya HS; Thakkar VR
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):715-21. PubMed ID: 18951284
[TBL] [Abstract][Full Text] [Related]
2. DNA interactions and promotion in antibacterial activities of ciprofloxacin drug due to formation of mixed-ligand complexes of oxovanadium(IV).
Patel MN; Patel SH; Chhasatia MR; Desai CR
Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):200-15. PubMed ID: 20408051
[TBL] [Abstract][Full Text] [Related]
3. Five-coordinated oxovanadium(IV) complexes derived from amino acids and ciprofloxacin: synthesis, spectral, antimicrobial, and DNA interaction approach.
Patel MN; Patel SH; Chhasatia MR; Parmar PA
Bioorg Med Chem Lett; 2008 Dec; 18(24):6494-500. PubMed ID: 18993070
[TBL] [Abstract][Full Text] [Related]
4. Metal-based biologically active compounds: synthesis, characterization, DNA interaction, antibacterial, cytotoxic and SOD mimic activities.
Patel MN; Patel CR; Joshi HN
Appl Biochem Biotechnol; 2013 Feb; 169(4):1329-45. PubMed ID: 23306896
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, antibacterial activity, SOD mimic and interaction with DNA of drug based copper(II) complexes.
Patel MN; Dosi PA; Bhatt BS; Thakkar VR
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Feb; 78(2):763-70. PubMed ID: 21212015
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial and DNA interaction studies of zinc(II) complexes with quinolone family member, ciprofloxacin.
Patel M; Chhasatia M; Parmar P
Eur J Med Chem; 2010 Feb; 45(2):439-46. PubMed ID: 19913957
[TBL] [Abstract][Full Text] [Related]
7. Metal based biologically active compounds: design, synthesis, and antibacterial/antifungal/cytotoxic properties of triazole-derived Schiff bases and their oxovanadium(IV) complexes.
Chohan ZH; Sumrra SH; Youssoufi MH; Hadda TB
Eur J Med Chem; 2010 Jul; 45(7):2739-47. PubMed ID: 20338672
[TBL] [Abstract][Full Text] [Related]
8. DNA-interaction and in vitro antimicrobial studies of some mixed-ligand complexes of cobalt(II) with fluoroquinolone antibacterial agent ciprofloxacin and some neutral bidentate ligands.
Patel MN; Chhasatia MR; Gandhi DS
Bioorg Med Chem Lett; 2009 May; 19(10):2870-3. PubMed ID: 19359174
[TBL] [Abstract][Full Text] [Related]
9. Interaction of drug based binuclear mixed-ligand complexes with DNA.
Patel MN; Chhasatia MR; Gandhi DS
Bioorg Med Chem; 2009 Aug; 17(15):5648-55. PubMed ID: 19581101
[TBL] [Abstract][Full Text] [Related]
10. New Cu(II), Co(II), Ni(II) complexes with aroyl-hydrazone based ligand. Synthesis, spectroscopic characterization and in vitro antibacterial evaluation.
Angelusiu MV; Barbuceanu SF; Draghici C; Almajan GL
Eur J Med Chem; 2010 May; 45(5):2055-62. PubMed ID: 20133023
[TBL] [Abstract][Full Text] [Related]
11. Influence of the cell wall on ciprofloxacin susceptibility in selected wild-type Gram-negative and Gram-positive bacteria.
Berlanga M; Montero MT; Hernández-Borrell J; Viñas M
Int J Antimicrob Agents; 2004 Jun; 23(6):627-30. PubMed ID: 15194135
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, spectroscopic characterization, antimicrobial, DNA binding and oxidative-induced DNA cleavage activities: new oxovanadium(IV) complexes of 2-(2-hydroxybenzylideneamino)isoindoline-1,3-dione.
Shivakumar L; Shivaprasad K; Revanasiddappa HD
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Nov; 97():659-66. PubMed ID: 22863547
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure, DNA binding and DNA cleavage activity of oxovanadium(IV) N-salicylidene-S-methyldithiocarbazate complexes of phenanthroline bases.
Sasmal PK; Patra AK; Chakravarty AR
J Inorg Biochem; 2008 Jul; 102(7):1463-72. PubMed ID: 18279964
[TBL] [Abstract][Full Text] [Related]
14. Nucleic acid interaction and antibacterial behaviours of a ternary palladium(II) complexes.
Patel MN; Dosi PA; Bhatt BS
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Feb; 86():508-14. PubMed ID: 22153744
[TBL] [Abstract][Full Text] [Related]
15. Photocytotoxic oxovanadium(IV) complexes showing light-induced DNA and protein cleavage activity.
Sasmal PK; Saha S; Majumdar R; Dighe RR; Chakravarty AR
Inorg Chem; 2010 Feb; 49(3):849-59. PubMed ID: 20039725
[TBL] [Abstract][Full Text] [Related]
16. Induction of cell death by ternary copper(II) complexes of L-tyrosine and diimines: role of coligands on DNA binding and cleavage and anticancer activity.
Ramakrishnan S; Rajendiran V; Palaniandavar M; Periasamy VS; Srinag BS; Krishnamurthy H; Akbarsha MA
Inorg Chem; 2009 Feb; 48(4):1309-22. PubMed ID: 19140687
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of dinuclear macrocyclic cobalt(II), copper(II) and zinc(II) complexes derived from 2,2,2('),2(')-S,S[bis(bis-N,N-2-thiobenzimidazolyloxalato-1,2-ethane)]: DNA binding and cleavage studies.
Arjmand F; Aziz M
Eur J Med Chem; 2009 Feb; 44(2):834-44. PubMed ID: 18579258
[TBL] [Abstract][Full Text] [Related]
18. Topoisomerase inhibition, nucleolytic and electrolytic contribution on DNA binding activity exerted by biological active analogue of coordination compounds.
Patel MN; Bhatt BS; Dosi PA
Appl Biochem Biotechnol; 2012 Apr; 166(8):1949-68. PubMed ID: 22391694
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin.
Jiménez-Garrido N; Perelló L; Ortiz R; Alzuet G; González-Alvarez M; Cantón E; Liu-González M; García-Granda S; Pérez-Priede M
J Inorg Biochem; 2005 Mar; 99(3):677-89. PubMed ID: 15708788
[TBL] [Abstract][Full Text] [Related]
20. Investigation of DNA binding mechanism, photoinduced cleavage activity, electrochemical properties and biological functions of mixed ligand copper(II) complexes with benzimidazole derivatives: synthesis and spectral characterization.
Raman N; Selvan A
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):380-9. PubMed ID: 21732720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
